Company intelligence / Profile preview

天津济坤医药科技

Tianjin, Tianjin, China

Ownership: Private
Development stage: Other

Overview

Tianjin Jikun Pharmaceutical Technology is a Chinese biotechnology company dedicated to the research, development, and technical transfer of medicinal technologies. Founded in 2019 and based in the Binhai New Area of Tianjin, the company focuses on the synthesis of pharmaceutical intermediates and the optimization of chemical processes for small molecule drugs. It offers a range of services including technical consultation and R&D outsourcing to support the pharmaceutical industry. The firm operates as a research-driven entity serving the broader life sciences and healthcare sectors through technical innovation and process development.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on 天津济坤医药科技.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 天津济坤医药科技.

Explore the full profile